The Miami Entrepreneur

Scholar Rock’s stock soars more than 230% on positive trial of treatment for spinal muscular atrophy

Read Time:4 Second

The Phase 3 trial of Apitegromab showed statistically significant improvement in motor function.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Lineker says BBC contract talks have just started
Next post Apple’s stock draws a downgrade as AI optimism may be very premature